Genetic association study of putative functional single nucleotide polymorphisms of genes in folate metabolism and spina bifida

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 4, 2009, Pages 394.e1-394.e11

  Martinez, Carla A ^a   Northrup, Hope ^a   Lin, Jone Ing ^b   Morrison, Alanna C ^b   Fletcher, Jack M ^c   Tyerman, Gayle H ^d   Au, Kit Sing ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c EAST TEXAS MEDICAL CENTER   (United States)

^d SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

folate homocysteine metabolism genes; single nucleotide polymorphism; spina bifida

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; DIHYDROFOLATE REDUCTASE; THYMIDYLATE SYNTHASE;

ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; CLINICAL STUDY; DNA EXTRACTION; ETHNICITY; FEMALE; FOLATE METABOLISM; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SPINA BIFIDA;

EID: 70349322403     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.06.042     Document Type: Article

References (43)

1. Centers for Disease Control and Prevention (CDC). Racial/ethnic differences in the birth prevalence of spina bifida-United States, 1999-2005. [erratum in MMWR Morb Mortal Wkly Rep 2009;58:61]. MMWR Morb Mortal Wkly Rep 57 (2009) 1409-1413
2. Martin J.A., Hamiliton B.E., Sutton P.D., et al. Births: final data for 2006. Natl Vital Stat Rep 57 (2009) 1-102
3. Sadler T.W. Embrology of neural tube development: embryology of neural tube development. Am J Med Genet C Semin Med Genet 135C (2005) 2-8
4. Botto L.D., Moore C.A., Khoury M.J., and Erickson J.D. Neural-tube defects. N Engl J Med 341 (1999) 1509-1519
5. Molloy A.M., Kirke P.N., Troendle J.F., et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defects prevalence and no folic acid fortification. Pediatrics 123 (2009) 917-923
6. Czeizel A.E., and Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327 (1992) 1832-1835
7. Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 338 (1991) 131-137
8. Lumley J., Watson L., Watson M., and Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 3 (2001) CD001056
9. Honein M.A., Paulozzi L.J., Mathews T.J., Erickson J.D., and Wong L.Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285 (2001) 2981-2986
10. Berry R.J., Li Z., Erickson J.D., et al. Prevention of neural-tube defects with folic acid in China: China-US collaborative project for neural tube defect prevention. [erratum in N Engl J Med 1999;341:1864]. N Engl J Med 341 (1999) 1485-1490
11. Olney R., and Mulinare R. Epidemiology of neural tube defects. Ment Retard Dev Disabil Res Rev 4 (1998) 241-246
12. van der Put N.M., Steegers-Theunissen R.P., Frosst P., et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346 (1995) 1070-1071
13. Volcik K.A., Blanton S.H., Tyerman G.H., et al. Methylenetetrahydrofolate reductase and spina bifida: evaluation of level of defect and maternal genotypic risk in Hispanics. Am J Med Genet 95 (2000) 21-27
14. Félix T.M., Leistner S., and Giugliani R. Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil. Birth Defects Res A Clin Mol Teratol 70 (2004) 459-463
15. Kirke P.N., Mills J.L., Molloy A.M., et al. Impace of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ 328 (2004) 1535-1536
16. Botto L.D., and Yang Q. 5, 10-Methyltetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151 (2000) 862-877
17. Au K.S., Tran P.X., Tsai C.C., et al. Characteristics of a spina bifida population including North American Caucasian and Hispanic individuals. Birth Defects Res A Clin Mol Teratol 82 (2008) 682-700
18. Martin Y.N., Salavaggione O.E., Eckloff B.W., Wieben E.D., Schaid D.J., and Weinshilboum R.M. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics. Pharmacogenet Genomics 16 (2006) 265-277
19. Wilding C.S., Relton C.L., Sutton M.J., et al. Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from northern United Kingdom. Birth Defects Res A Clin Mol Teratol 70 (2004) 483-485
20. van der Linden I.J., Nguyen U., Heil S.G., et al. Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. Mol Genet Metab 91 (2007) 98-103
21. van der Linden I.J., Heil S.G., Kouwenberg I.C., den Heijer M., and Blom H.J. The methylenetetrahydrofolate dehydrogenase (MTHFD1) 1958G>A variant is not associated with spina bifida risk in the Dutch population. Clin Genet 72 (2007) 599-600
22. Johnson W.G., Stenroos E.S., Spychaia J.R., Chatkupt S., Ming S.X., and Buyske S. New 19 bp deletion polymorphism in intron-1 dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy?. Am J Med Genet 124A (2004) 339-345
23. Enzinger C., Wirleitner B., Spottl N., Bock G., Fuchs D., and Baier-Bitterlich G. Reduced pteridine derivatives induce apoptosis in PC12 cells. Neurochem Int 41 (2002) 71-78
24. Spottl N., Wirleitner B., Bock G., Widner B., Fuchs D., and Baier-Bitterlich G. Reduced pteridine derivatives induce apoptosis in human neuronal NT2/HNT cells. Immunobiology 201 (2000) 478-491
25. Davidson C., Northrup N., King T.M., et al. Genes in glucose metabolism and association with spina bifida. Reprod Sci 15 (2008) 51-58
26. Knapp M. The transmission/disequilibrium test and parental-genotype reconstruction: the reconstruction-combined transmission/disequilibrium test. Am J Hum Genet 64 (1999) 861-870
27. Knapp M. Reconstructing parental genotypes when testing for linkage in the presence of association. Theor Popul Biol 60 (2001) 141-148
28. Boyles A.L., Billups A.V., Deak K.L., et al. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect 114 (2006) 1547-1552
29. O'Leary V.B., Mills J.L., Pangilinan F., et al., Members of the Birth Defects Research Group. Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab 85 (2005) 220-227
30. Steegers-Theunissen R.P., Boers G.H., Blom H.J., et al. Neural-tube defects and elevated homocysteine levels in amniotic-fluid. Am J Obstet Gynecol 172 (1995) 1436-1441
31. Mills J.L., McPartlin J.M., Kirke P.N., et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345 (1995) 149-151
32. Felkner M., Suarez L., Canfield M.A., Brender J.D., and Sun Q. Maternal serum homocysteine and risk for neural tube defects in a Texas-Mexico border population. Birth Defects Res A Clin Mol Teratol 85 (2009) 574-581
33. Morrison K., Papapetrou C., Hol F.A., et al. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 62 (1998) 379-396
34. de Franchis R., Botto L.D., Sebastio G., et al. Spina bifida and folate related genes: a study of gene-gene interactions. Genet Med 4 (2002) 126-130
35. Fredriksen A., Meyer K., Ueland P.M., Vollset S.E., Grotmol T., and Schneede J. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 28 (2007) 856-865
36. Chen X., Wang L., Fazlieva R., and Kruger W.D. Contrasting behaviors of mutant cystathionine beta-synthase enzymes associated with pyridoxine response. Hum Mutat 27 (2006) 474-482
37. Parle-McDermott A., Pangilinan F., Mills J.L., et al. The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population. Am J Med Genet Part A 143A (2007) 1174-1180
38. Akar N., Akar E., Egin Y., Deda G., Arsan S., and Ekim M. Neural tube defects and 19 bp deletion within intron-1 of dihydrofolate reductase gene. Turk J Med Sci 38 (2008) 383-386
39. van der Put N.M.J., Gabreels F., Stevens E.M.B., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 (1998) 1044-1051
40. O'Leary V.B., Mills J.L., Parle-McDermott A., et al. Screening for new MTHFR polymorphisms and NTD risk. Am J Med Genet 138A (2005) 99-106
41. Relton C.L., Wilding C.S., Pearce M.S., et al. Gene-gene interactions in a folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41 (2004) 256-260
42. Speer M.C., Nye J., McLone D., et al. Possible interaction of genotypes at cystathionine β-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. Clin Genet 56 (1999) 142-144
43. Volcik K.A., Shaw G.M., Zhu H., Lammer E.J., Laurent C., and Finnell R.H. Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res A Clin Mol Teratol 67 (2003) 924-928